SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024 USD ($)	Dec. 30, 2023 USD ($)	Dec. 28, 2024 USD ($) segment	Dec. 30, 2023 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment			3
Net revenues in constant currency	$ 349,367	$ 337,713	$ 1,032,407	$ 967,864
Effect of exchange rates	(825)	(1,463)	(2,182)	(2,099)
Net revenues	348,542	336,250	1,030,225	965,765
Operating income	59,029	45,978	150,482	134,940
Effect of exchange rates	304	(401)	267	(879)
Amortization of acquired intangible assets	12,230	6,911	36,965	21,606
Amortization of fair value inventory step-up	3,341	0	12,319	0
Integration and transaction costs	(244)	(4,869)	(13,449)	(7,768)
Restructuring costs	(3,515)	(7,968)	12,929	8,043
Restructuring related costs	1,468	2,403	5,557	6,554
Digital transformation costs	4,620	3,415	15,823	10,712
Write downs of certain assets and PCS2 related charges	(4,000)	(210)	4,000	(621)
MDR and IVDR costs	(1,008)	(1,433)	(3,125)	(4,587)
Litigation-related charges	18	(177)	(1,057)	(6,684)
Impairment of intangible assets	0	0	(2,391)	(10,419)
Gain on sale of property, plant and equipment	0	0	14,134	0
United States
Segment Reporting Information [Line Items]
Net revenues	257,665	250,804	762,628	724,222
Japan
Segment Reporting Information [Line Items]
Net revenues	16,174	14,825	46,303	41,609
Europe
Segment Reporting Information [Line Items]
Net revenues	44,163	37,035	133,379	115,088
Rest of Asia
Segment Reporting Information [Line Items]
Net revenues	25,597	30,935	71,148	80,710
Other
Segment Reporting Information [Line Items]
Net revenues	4,943	2,651	16,767	4,136
Plasma
Segment Reporting Information [Line Items]
Net revenues in constant currency	134,389	147,560	408,996	429,694
Restructuring related costs	37	72	263	315
Plasma | Plasma
Segment Reporting Information [Line Items]
Net revenues	134,224	147,641	408,695	430,056
Blood Center
Segment Reporting Information [Line Items]
Net revenues in constant currency	70,730	73,528	206,373	213,167
Restructuring related costs	31	93	120	166
Blood Center | Blood Center
Segment Reporting Information [Line Items]
Net revenues	70,345	72,379	205,118	211,241
Apheresis | Blood Center
Segment Reporting Information [Line Items]
Net revenues	55,388	52,565	158,814	156,704
Whole Blood | Blood Center
Segment Reporting Information [Line Items]
Net revenues	14,957	19,814	46,304	54,537
Hospital
Segment Reporting Information [Line Items]
Net revenues in constant currency	144,248	116,625	417,038	325,003
Restructuring related costs	(68)	251	40	398
Hospital | Hospital
Segment Reporting Information [Line Items]
Net revenues	143,973	116,230	416,412	324,468
Vascular Closure, Hosptial | Hospital
Segment Reporting Information [Line Items]
Net revenues	63,253	43,007	188,220	119,168
Hemostasis Management, Hospital | Hospital
Segment Reporting Information [Line Items]
Net revenues	80,720	73,223	228,192	205,300
Operating Segments
Segment Reporting Information [Line Items]
Operating income	159,406	157,459	458,356	447,566
Operating Segments | Plasma
Segment Reporting Information [Line Items]
Operating income	70,337	80,450	205,902	234,190
Operating Segments | Blood Center
Segment Reporting Information [Line Items]
Operating income	26,955	27,654	76,744	81,244
Operating Segments | Hospital
Segment Reporting Information [Line Items]
Operating income	62,114	49,355	175,710	132,132
Corporate
Segment Reporting Information [Line Items]
Operating income	$ 70,273	$ 83,694	$ 214,660	$ 234,753